Search for: rheumatoid arthritis methotrexate autoimmune disease biomarker gene expression GWAS HLA genes non-HLA genes
| ID | PMID | Title | PublicationDate | abstract |
|---|---|---|---|---|
| 1613699 | Illness intrusiveness in rheumatoid arthritis: differential impact on depressive symptoms | 1992 May | Depressive symptoms in rheumatoid arthritis (RA) were hypothesized to derive from illness intrusiveness--illness-induced lifestyle disruptions. Differences over the adult lifespan were also investigated in 110 outpatients with RA, aged 24-78 years who completed standardized psychological tests. A significant Age x Illness Intrusiveness interaction indicated that depressive symptoms intensified more sharply among comparatively younger vs older individuals as the intrusiveness of RA increased. We conclude illness intrusiveness is an important determinant of depressive symptoms in RA. However, its impact may vary over the course of adult psychological development. | |
| 1464866 | Kates forefoot arthroplasty in rheumatoid arthritis. A 5-year followup study. | 1992 Oct | The longterm results of Kates forefoot arthroplasty in 74 feet of 41 patients with rheumatoid arthritis (RA) after a mean followup of 5.2 years was considered to be good by 38 patients and poor by 3 patients. The average walking distance had doubled. The mean hallux valgus angle was reduced from 46 to 27 degrees. Surgical results proved to depend on the quality of the arc of the remaining stumps, and not on the severity or activity of RA. Reoperations were necessary in 16 feet of 10 patients because of too prominent distal metatarsal stumps. Despite the absence of pain, 28 patients were not satisfied with the function of the hallux. This might be improved by performing arthrodesis of the first metatarsophalangeal joint. | |
| 8299258 | Anti-RA 33 as a marker antibody of rheumatoid arthritis in a Finnish population. | 1993 Nov | To obtain information on anti-RA 33 as a marker antibody of rheumatoid arthritis (RA), a panel of Finnish sera were tested by immunoblotting with partially purified RA 33 antigen. Six of 100 specimens from patients with RA, one of 39 specimens from subjects who later developed seropositive RA, and one of 50 specimens from subjects with "false-positive" rheumatoid factor reactions were positive. The findings are compatible with the concept that anti-RA 33 is associated with RA from its onset and can even precede the disease. However, the prevalence of this antibody in Finnish RA patients is remarkably low compared to patients from continental Europe. | |
| 8511637 | Tobit, fixed effects, and cohort analyses of the relationship between severity and duratio | 1993 Jun | Three methodological problems are commonly faced by researchers investigating relationships between severity and duration of illness among patients with rheumatoid arthritis (RA). (1) Linear regression techniques yield biased estimates when measures of severity are continuous but range between and include limiting values such as 0 and 3. (2) Data from the same patient over time are typically pooled together with data from different patients at the same time and over time. Models are then used that do not account for the statistical problems that can result from pooling. (3) Persons with varying years of duration of disease are typically combined and analyzed without any special attention to cohort effects. Changes in severity over time for cohorts of patients with fewer than 10 years of duration may be different from changes in severity of patients with more than 20 years of duration from the onset of the disease. In this study, severity is measured by the 0-3 disability scale in the Stanford Health Assessment Questionnaire (HAQ). Duration is measured by self-report of the onset of symptoms by subjects. Popular techniques are borrowed from econometrics--Tobit, Fixed Effects, and dummy variables for Cohort Models--that were developed to address three analogous problems in economic data. The three economic techniques are applied separately and together using data collected by Arthritis, Rheumatism, and Aging Medical Information System (ARAMIS) on 330 RA patients in 1981 who were followed until 1989. Although the Tobit technique does not appear to be especially useful with these data, Fixed Effects and Cohort Models do appear to be useful.(ABSTRACT TRUNCATED AT 250 WORDS) | |
| 1737234 | Effect of dominancy on severity in rheumatoid arthritis. | 1992 Feb | Joint use has been felt to increase the severity of rheumatoid synovitis. Ninety-three patients with definite or classical rheumatoid arthritis (RA) were studied blind for clinical and radiological findings to see the effect of dominancy on the severity of the arthritis. The dominant side showed significantly greater total swelling scores (P less than 0.0001) and total tenderness scores (P less than 0.01). This was explained predominantly by greater severity of arthritis in dominant arms and hands. X-rays of the dominant hands and wrists showed more joint space narrowing (P less than 0.04) and erosion (P less than 0.01), but no differences in malalignment scores. There were no differences between dominant and non-dominant sides on frequency of intra-articular injections or use of splinting, but the dominant side received more surgical operations (P less than 0.02). | |
| 8868148 | Psychotherapy in rheumatoid arthritis--a parallel-process study of psychic state and cours | 1996 Jan | In this study, well-known psychosomatic (psychoneuroimmunological) connections have been used for therapeutic purposes. Fifteen patients with rheumatoid arthritis (RA) were treated with analytical insight therapy for 60-90 min weekly during 10 months to 4.5 years (median 3.3 years). Six patients showed great and largely continuous improvement, both psychic and physical, throughout the period of psychotherapy and often for a long time thereafter. In another five cases, improvements in psychic state and the joint disease took place over a period of 1-2 years. Later, when the emotional channels to childhood traumata were opened, these five patients relapsed and the course of their disease became more variable. In four cases, the connections between psychic state and the course of the joint disease were more varied throughout the period of psychotherapy. In the studied group the correlation between psychic state and course of rheumatic disease was highly significant. The probability of the outcome of the study being due to chance alone is considered very small, especially taking into account the fact that RA is a chronic progressive disease. | |
| 8081667 | The incidence of rheumatoid vasculitis in the Norwich Health Authority. | 1994 Sep | Systemic rheumatoid vasculitis (SRV) is an uncommon but potentially serious complication of RA. The incidence of SRV is unknown. The aim of this study was to estimate the incidence of SRV in the UK. Over a 6-yr period vigorous attempts were made to identify all patients with newly diagnosed SRV living within the Norwich Health Authority (NHA). The overall annual incidence of SRV is 12.5/million (95% CI: 8.5-17.7). The annual incidence rate for men was 15.8/million (95% CI: 9.5-24.7) and 9.4/million (95% CI: 4.8-16.4) for women. The incidence of SRV in this study is higher than previous estimates. | |
| 8295177 | How often is seropositive rheumatoid arthritis an erosive disease? A 17-year followup stud | 1993 Oct | OBJECTIVE: The frequency of erosiveness was studied in rheumatoid arthritis (RA) by longterm followup. METHODS: A community based cohort of 263 patients with recent onset (< or = 6 months) arthritis were followed in Heinola. At 8-year followup examination 113 cases were found to have rheumatoid factor positive (seropositive) nonspecific arthritis, and 15 were nonerosive in the radiographs. The 15 patients were reexamined in 1992 (17-year followup). RESULTS: Eleven of 15 were found to have erosive disease, and of these, 6 had putative psoriatic arthritis, 4 RA, and one monoarthritis of the knee. Of the remaining 4 seropositive nonerosive cases only one fulfilled the 1987 American College of Rheumatology (ARA) criteria for RA. CONCLUSION: In patients with seropositive RA with 4 1987 ARA criteria, 99% developed erosive disease. | |
| 1475633 | Safety aspects of the long term cyclosporin A therapy. | 1992 | The long term safety issues of cyclosporin A therapy of rheumatoid arthritis can be classified into two categories: side effects typical for the cyclosporin group of drugs and side effects due to the immunosuppression. A decrease in the renal function and elevation of the blood pressure are the main cyclosporin-related side effects. Blood pressure can be controlled in most cases by dose reduction or by antihypertensive therapy. With the current low dose strategy, a mild decrease of renal function is common but the incidence of permanent renal damage is low and the prognosis is good. Immunosuppression as such may predispose for malignancies and infections. Cyclosporin A is not mutagenic. However, it may impair the immunosurveillance for transformed cells. Data from organ transplantation suggest that immunosuppressive regimens including cyclosporin A increase the incidence of lymphoproliferative disorders and skin cancers. It is not clear whether cyclosporin A can increase the incidence of these tumors in patients with rheumatoid arthritis due to a relatively small number of patients studied thus far. Monitoring of cyclosporin A therapy of rheumatoid arthritis is simple but mandatory. | |
| 9020562 | Assessment of beta-2-microglobulin concentration in serum and urine in rheumatoid arthriti | 1996 | Assessment of beta-2-microglobulin (beta-2-M) concentration in serum and urine was made in 50 patients with rheumatoid arthritis (RA). The most often noticed pathology was proteinuria. We observed a significant increase of beta-2-M concentration in serum of patients without rheumatoid factor and in patients with proteinuria. In all patients the concentration of beta-2-M in urine was significantly higher than in the controls. We did not observe any influence after treatment on beta-2-M concentration. The increase of the concentration of beta-2-M may be a marker for the early damage of kidney in RA. | |
| 8093995 | Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthrit | 1993 Jan | Serum soluble interleukin 2 receptor (sIL-2R) concentrations reflect lymphocyte activation in vivo. An investigation was carried out to determine if sIL-2R concentrations correlate with existing disease activity parameters in patients with rheumatoid arthritis (RA) and whether these concentrations are modulated by treatment with second line drugs. Seventy nine patients with rheumatoid arthritis with active disease were prospectively treated with sodium aurothiomalate, auranofin, or sulphasalazine. Sequential concentrations of sIL-2R were measured by enzyme linked immunosorbent assay (ELISA). No correlations were observed between sIL-2R concentrations and clinical parameters and there were only moderate associations with concentrations of C reactive protein and the erythrocyte sedimentation rate. Concentrations of sIL-2R did not significantly change with treatment. It is concluded that sIL-2R probably measures an aspect of rheumatoid synovitis distinct from acute phase reactants and is not influenced by treatment with second line drugs. | |
| 8717100 | Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap | 1996 | Patients with rheumatoid arthritis (RA) showed significantly (P < 0.01) increased numbers of granulocytes in their peripheral blood compared with normal donors and patients with osteoarthritis, and this finding correlated with interleukin-6 and C-reactive protein levels and active joint score. Then, 17 patients with RA were treated eight times in 4 weeks with a newly developed extracorporeal granulotrap column containing cellulose acetate beads (G-1 column). This column reduced granulocytes in the outflow blood by 50.2% compared with inflow counts. To evaluate the efficacy of G-1 therapy, 17 patients were followed for 12 weeks from the beginning of this therapy. The modified Lansbury index (LI) for monitoring RA activity significantly improved from a pretreatment mean score of 60.8% to a posttreatment score of 51.3%. The lowered scores were maintained up to 12 weeks after the initiation of therapy. Of the four LI items, tender and swollen joint scores showed the most significant improvement, with the tender joint score showing a particularly significant decrease throughout the study period. No serious side-effects were observed. These findings suggested that G-1 therapy was effective for RA. | |
| 7869302 | The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zi | 1994 Nov | OBJECTIVE: To compare the clinical, serologic and radiologic expression of rheumatoid arthritis (RA) in UK Caucasian and ethnic black patients from Zimbabwe. METHODS: Standardized protocols and assessment criteria were used to study 84 black patients with no non-Bantu antecedents and 84 UK Caucasian patients with RA (matched for disease duration, sex and age). RESULTS: Articular manifestations of RA were less severe in the black patients with RA from Zimbabwe as shown by less early morning stiffness (p = 0.001), fewer patients with > or = 3 active joints (p = 0.01), fewer joint deformities (p = 0.004) and better grip strength (p = 0.001) in comparison to the white patients with RA from the UK. Caucasian patients had a higher frequency of extraarticular manifestations (p = 1 x 10(-6)) including rheumatoid nodules (p = 0.0001), Raynaud's (p = 0.01) and Sicca syndrome (p = 0.001). Toxic effects from disease modifying antirheumatic drugs occurred less frequently in black patients (p = 0.0002). More white patients had Ro and La antibodies. The radiologic changes in the black patients were less severe than those in the white patients. The distribution of erosions in hands and feet were different in the 2 groups of patients studied. There were no differences between the urban and rural black patients but a more detailed study involving a large number of patients is required to confirm this observation. CONCLUSION: Black patients with RA from Zimbabwe have a disease that is clinically and radiologically less severe with fewer extraarticular features when compared to UK white patients. | |
| 1629817 | Comparison of the sensitivity and specificity of the 1958 and 1987 criteria for rheumatoid | 1992 Feb | The 2 variations of the new criteria for rheumatoid arthritis (RA) proposed by a subcommittee of the American College of Rheumatology (ACR) in 1987 were evaluated and compared with the earlier (1958) criteria in 2 patients data collections from a Dutch rheumatological outpatient clinic. One group comprised 1,570 newly referred, consecutive patients, including 93 patients with RA. The other consisted of 1,338 patients with a clinical diagnosis of RA, whose charts were reviewed retrospectively. The sensitivities of the 2 variations of the 1987 criteria in the prospective and retrospective subgroups varied from 66 to 89%; those of the 1958 set, from 71 to 86%. Specificity was 98% for both criteria sets. Comparison in subgroups with different disease durations showed reduction in sensitivity for early RA for either variation of the new criteria. However, the differences between the results of the 1958 and 1987 criteria sets are small enough to conclude that they perform equally well. | |
| 8297297 | Septic arthritis of the hip in infancy. | 1993 Feb | A retrospective study was undertaken of 24 infants with septic arthritis of one or both hips who presented to the Children's Hospital, Camperdown, during the 15 year period from 1973 to 1989. Staphylococcus aureus was found to be the most common pathogen. Umbilical catheterization was a significant aetiological factor in seven of 10 neonates studied. Young premature infants had the poorest outcome in regard to permanent bony changes in the upper femur, hip instability and leg length discrepancy. In patients with unstable and severely damaged upper femora, late salvage procedures were found to be unsatisfactory. | |
| 8920624 | Rheumatoid nodules affecting both heels with surgical debulking: a case report*. | 1996 Apr | The presence of subcutaneous nodules in association with rheumatoid arthritis is well documented. In most cases, these nodules occur in association with severe rheumatoid disease. Treatment should be initiated with conservative measures such as custom-molded shoes, nonweightbearing, and oral antibiotic therapy to control infection. The goals of surgery were to alleviate pain, improve function and cosmesis, remove infected bone, and prevent further infection. The surgical sites are completely healed without complications 2 years postoperatively. | |
| 1465690 | Nutritional status in rheumatoid arthritis. Effects of disease activity, corticosteroid th | 1992 Dec | Sixty-five patients with rheumatoid arthritis (RA) (mean age 37.2 years) were compared with 71 controls (mean age 33.8 years). Anthropometric measurements included body diameters and skin-fold thickness at multiple sites, while biochemical markers of nutritional status included serum albumin, thyroxine-binding pre-albumin and retinol-binding globulin levels. None of the RA subjects was outside the range that extended 2 standard deviations above and below the normal control values for lean body mass. Discriminant analysis showed that corticosteroid therapy did not significantly influence skinfold thickness in RA. A combination of bi-acromial and bi-ankle diameters had a sensitivity of 70% and a specificity of 72% in differentiating the RA group, in whom disease activity had a greater effect on body diameters than corticosteroid therapy did. Differences related to functional impairment were a manifestation of disease activity rather than a direct effect on skinfold thickness or body diameters. According to anthropometric measurements in ambulant patients, RA does not result in malnutrition in young individuals. | |
| 8301987 | [Plasmapheresis in the combined treatment of rheumatoid arthritis, complicated with anemia | 1993 | Time course of changes in hemostasis were investigated in 68 rheumatoid arthritis (RA) patients. DIC syndrome and anemia were recorded in 23 and 20 patients, respectively. Three RA sufferers were free of anemia. A course of plasma-pheresis proved effective against DIC syndrome in 12 anemic and 2 nonanemic patients. Alleviation of DIC syndrome occurred in association with improvement in the red cell count and inhibition of rheumatoid process activity. In persistent DIC syndrome a trend to normalization of the above parameters was insignificant. | |
| 8151588 | The effect of methotrexate on ex vivo lipoxygenase metabolism in neutrophils from patients | 1994 Jan | OBJECTIVE: To examine the effect of methotrexate (MTX) administered in vivo on the production of the 5-lipoxygenase (5-LO) metabolites of arachidonic acid by neutrophils from subjects with rheumatoid arthritis. METHODS: Neutrophils were isolated from peripheral blood samples taken 12 h before and 12 h after the ingestion of an oral dose of MTX and stimulated in vitro by calcium ionophore A23187. Lipid extracts of cell suspensions were assayed for leukotriene B4 (LTB4), the all-trans isomers of LTB4, 20-hydroxy LTB4 and 5-hydroxyeicosatetraenoic acid by high pressure liquid chromatography. RESULTS: An increase in the production of all measured 5-LO metabolites was seen between the pre and postdose assessments. CONCLUSION: Our results do not support the putative inhibitory effect of MTX on 5-LO metabolism. | |
| 8783419 | Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patien | 1996 | The pyridinium crosslinks are important and definite biomarkers of mature hard tissue collagen degradation. A gradient ion-paired reversed-phase high-performance liquid chromatographic method was used for the simultaneous determination of both crosslinks in synovial fluid (SF) samples of 25 patients with rheumatoid arthritis (RA). The mean +/- SD levels of pyridinoline (Pyd) and deoxypyridinoline (Dpyd) in SF were 107.7 +/- 182.3 nmol/l and 4.8 +/- 8.3 nmol/l, respectively. The Pyd/Dpyd ratio, which indicates the amount of Pyd released from cartilage rather than bone, amounted to 30.8 +/- 29.5. This value is significantly higher than in urine or serum of the same patients. These data suggest increased destruction of joint cartilage in patients with RA and the release of collagen II fragments in SF. In addition, the levels of the crosslinks in SF reflect considerable interindividual variation, indicating substantial individual differences in the amount of collagenous material that is degraded. |